Mediterranean Plants May Fight Alzheimer’s, Parkinson’s: Neurodegenerative Diseases Treatment
The Mediterranean diet has been linked to significant health benefits for years, such as lowered blood pressure, and now new research has found that chemicals extracted from two plants found in the region - the prickly pear and brown seaweed - could potentially combat Alzheimer's and Parkinson's diseases.
Gut Microbiome Again Linked to Parkinson’s Symptoms
Alterations of bacteria in the gut are directly associated with the severity of motor deficits in Parkinson's disease mouse models, according to novel findings that, if replicated in humans, could eventually have clinical implications in the long-speculated relationship between gut bacteria and Parkinson's disease.
Early-Onset Parkinson’s Causes: Genetic Mutation Associated With Increased Risk For Disease Development
Parkinson's disease is caused by the deterioration of nerve cells in the brain, but it's still not clear what causes these cells to deteriorate in some people and not others. A new study has found a specific gene mutation linked to the early onset of Parkinson's disease.
Was Boxing To Blame For Parkinson’s Disease In Muhammad Ali?
Muhammad Ali was still boxing professionally when observers first noticed signs of neurological decline, and many have been quick to link his profession to his diagnosis, years later, of Parkinson's disease. In the decades that followed, and with Ali's death Friday at the age of 74, however, a stubborn fact remains: Neurologists cannot definitively say whether Ali's symptoms were a result of his boxing career.
New Protein Discovery Could Mean New Treatment For Parkinson’s Disease
First Posted: Jun 29, 2016 08:59 AM EDT Researchers have revealed that inhibiting the activity of a particular protein in the brain could stop or slow down the development of Parkinson's disease. So, it may be safe to say that new treatments for the disease are underway.
Parkinson’s: Predicting Risk and Progression
Two papers published this week address fundamental questions in Parkinson's disease: can researchers predict who will develop the disease, and once it's diagnosed, how will it progress? One, appearing in Lancet Neurology , described a predictive model based on an algorithmic combination of genetics, olfactory discrimination, and other factors that identified Parkinson's disease with 83% sensitivity and 90% specificity.